GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
1 hedge funds and large institutions have $4K invested in Genocea Biosciences, Inc. in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
Holders
1
Holders Change
-4
Holders Change %
-80%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
ACA
1
Avoro Capital Advisors
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AICPI
1
ABG Innovation Capital Partners III
Central, Hong Kong,
Hong Kong
| $4K | 375,000 | – | – |
|
|
ACA
2
Avoro Capital Advisors
New York
| – | – | -5,084,184 | Closed |
|
|
EAM
3
Empirical Asset Management
Wellesley,
Massachusetts
| – | – | -10,000 | Closed |
|
4
Simplex Trading
Chicago,
Illinois
| – | – | -500 | Closed |
|
5
Barclays
London,
United Kingdom
| – | – | -3 | Closed |
|